Literature DB >> 32980981

A NOTCH3 homozygous nonsense mutation in familial Sneddon syndrome with pediatric stroke.

Elli Katharine Greisenegger1,2, Sara Llufriu3, Angel Chamorro4,5, Alvaro Cervera6, Adriano Jimenez-Escrig7, Klemens Rappersberger8, Wolfgang Marik9, Stefan Greisenegger2, Elisabeth Stögmann2, Tamara Kopp10, Tim M Strom11,12, Jörg Henes12, Anne Joutel13, Alexander Zimprich14.   

Abstract

Sneddon syndrome is a rare disorder affecting small and medium-sized blood vessels that is characterized by the association of livedo reticularis and stroke. We performed whole-exome sequencing (WES) in 2 affected siblings of a consanguineous family with childhood-onset stroke and identified a homozygous nonsense mutation within the epidermal growth factor repeat (EGFr) 19 of NOTCH3, p.(Arg735Ter). WES of 6 additional cases with adult-onset stroke revealed 2 patients carrying heterozygous loss-of-function variants in putative NOTCH3 downstream genes, ANGPTL4, and PALLD. Our findings suggest that impaired NOTCH3 signaling is one underlying disease mechanism and that bi-allelic loss-of-function mutation in NOTCH3 is a cause of familial Sneddon syndrome with pediatric stroke.

Entities:  

Keywords:  CADASIL; Homozygous nonsense mutation; NOTCH3; Sneddon syndrome

Mesh:

Substances:

Year:  2020        PMID: 32980981      PMCID: PMC7914241          DOI: 10.1007/s00415-020-10081-5

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  26 in total

1.  Life history of cutaneous vascular lesions in Sneddon's syndrome.

Authors:  B Zelger; N Sepp; K W Schmid; H Hintner; G Klein; P O Fritsch
Journal:  Hum Pathol       Date:  1992-06       Impact factor: 3.466

2.  Loss-of-function mutation in the NOTCH3 gene: simply a polymorphism?

Authors:  Anne Joutel
Journal:  Hum Mutat       Date:  2013-11       Impact factor: 4.878

3.  Mutant ADA2 in vasculopathies.

Authors:  Jose Bras; Rita Guerreiro; Gustavo C Santo
Journal:  N Engl J Med       Date:  2014-07-31       Impact factor: 91.245

Review 4.  The diagnostic challenge of Divry van Bogaert and Sneddon Syndrome: Report of three cases and literature review.

Authors:  Anna Bersano; Michela Morbin; Elisa Ciceri; Gloria Bedini; Peter Berlit; Michele Herold; Stefania Saccucci; Valeria Fugnanesi; Hannes Nordmeyer; Giuseppe Faragò; Mario Savoiardo; Franco Taroni; MariaRita Carriero; Battista Boncoraglio Giorgio; Laura Perucca; Luigi Caputi; Agostino Parati Eugenio; Markus Kraemer
Journal:  J Neurol Sci       Date:  2016-03-05       Impact factor: 3.181

5.  Sneddon syndrome with or without antiphospholipid antibodies. A comparative study in 46 patients.

Authors:  C Francès; T Papo; B Wechsler; J L Laporte; V Biousse; J C Piette
Journal:  Medicine (Baltimore)       Date:  1999-07       Impact factor: 1.889

6.  Sneddon syndrome, arylsulfatase A pseudodeficiency and impairment of cerebral white matter.

Authors:  A Parmeggiani; A Posar; L B De Giorgi; S Sangiorgi; M Mochi; L Monari; A Patrizi; P G Rossi
Journal:  Brain Dev       Date:  2000-09       Impact factor: 1.961

7.  Sneddon's syndrome: diagnosis by skin biopsy and MRI in 17 patients.

Authors:  G Stockhammer; S R Felber; B Zelger; N Sepp; G G Birbamer; P O Fritsch; F T Aichner
Journal:  Stroke       Date:  1993-05       Impact factor: 7.914

8.  Homozygous NOTCH3 null mutation and impaired NOTCH3 signaling in recessive early-onset arteriopathy and cavitating leukoencephalopathy.

Authors:  Tommaso Pippucci; Alessandra Maresca; Pamela Magini; Giovanna Cenacchi; Vincenzo Donadio; Flavia Palombo; Valentina Papa; Alex Incensi; Giuseppe Gasparre; Maria Lucia Valentino; Carmela Preziuso; Annalinda Pisano; Michele Ragno; Rocco Liguori; Carla Giordano; Caterina Tonon; Raffaele Lodi; Antonia Parmeggiani; Valerio Carelli; Marco Seri
Journal:  EMBO Mol Med       Date:  2015-06       Impact factor: 12.137

9.  Transcriptomics of post-stroke angiogenesis in the aged brain.

Authors:  Ana Maria Buga; Claudiu Margaritescu; Claus Juergen Scholz; Eugen Radu; Christine Zelenak; Aurel Popa-Wagner
Journal:  Front Aging Neurosci       Date:  2014-03-18       Impact factor: 5.750

10.  ER stress and Rho kinase activation underlie the vasculopathy of CADASIL.

Authors:  Karla B Neves; Adam P Harvey; Fiona Moreton; Augusto C Montezano; Francisco J Rios; Rhéure Alves-Lopes; Aurelie Nguyen Dinh Cat; Paul Rocchicciolli; Christian Delles; Anne Joutel; Keith Muir; Rhian M Touyz
Journal:  JCI Insight       Date:  2019-12-05
View more
  6 in total

1.  NOTCH3 mutations in a cohort of Portuguese patients within CADASIL spectrum phenotype.

Authors:  Maria Rosário Almeida; Inês Elias; Carolina Fernandes; Rita Machado; Orlando Galego; Gustavo Santo
Journal:  Neurogenetics       Date:  2021-12-01       Impact factor: 2.660

2.  Stroke-associated intergenic variants modulate a human FOXF2 transcriptional enhancer.

Authors:  Jae-Ryeon Ryu; Suchit Ahuja; Corey R Arnold; Kyle G Potts; Aniket Mishra; Qiong Yang; Muralidharan Sargurupremraj; Douglas J Mahoney; Sudha Seshadri; Stéphanie Debette; Sarah J Childs
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-22       Impact factor: 12.779

3.  Early-Onset Vascular Leukoencephalopathy Caused by Bi-Allelic NOTCH3 Variants.

Authors:  Menno D Stellingwerff; Corinne Nulton; Guy Helman; Stefan D Roosendaal; William S Benko; Amy Pizzino; Marianna Bugiani; Adeline Vanderver; Cas Simons; Marjo S van der Knaap
Journal:  Neuropediatrics       Date:  2022-02-23       Impact factor: 1.696

4.  Novel heterozygous COL4A2 variant c.2572A > G, p.(I858V) mimicking Sneddon's and Divry van Bogaert Syndrome.

Authors:  Jan K Focke; Roland Veltkamp; Peter Bauer; Markus Kraemer
Journal:  J Neurol       Date:  2022-04-14       Impact factor: 6.682

Review 5.  Notch3 Signaling and Aggregation as Targets for the Treatment of CADASIL and Other NOTCH3-Associated Small-Vessel Diseases.

Authors:  Dorothee Schoemaker; Joseph F Arboleda-Velasquez
Journal:  Am J Pathol       Date:  2021-04-22       Impact factor: 4.307

Review 6.  Notch signalling in healthy and diseased vasculature.

Authors:  Francesca Del Gaudio; Dongli Liu; Urban Lendahl
Journal:  Open Biol       Date:  2022-04-27       Impact factor: 7.124

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.